LeafNLP Demos
Back to explore

Report #2884760

Received Feb 9, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
Jan 13, 2026
Onset
Jan 14, 2026
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICSUNKUNK—

Symptoms (2)

RashRash pruritic

Symptom narrative

Itchy rash down the arm; This non-serious case was reported by a consumer and described the occurrence of itchy rash in a 79-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Concomitant products included sutimlimab. On 13-JAN-2026, the patient received Bexsero. On 14-JAN-2026, 1 days after receiving Bexsero, the patient experienced itchy rash (Verbatim: Itchy rash down the arm). On 22-JAN-2026, the outcome of the itchy rash was resolved (duration 8 days). It was unknown if the reporter considered the itchy rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the itchy rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-FEB-2026 The batch number was not provided, and we are unable to contact the reporter.

Other medications

SUTIMLIMAB